Michel Baijot News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michel baijot. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michel Baijot Today - Breaking & Trending Today
20Med Therapeutics Appoints Industry Veteran Hugo Fry as Chief Business Officer to Expedite mRNA Vaccine Delivery Platform Program streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the appointment of Hugo. ....
Quebec City, QC – GlaxoSmithKline says it is nearing completion of a two-year, $199-million upgrade and expansion of its Quebec City influenza vaccine manufacturing facility. As a result, the facility is now a key global influenza vaccine manufacturing site, supporting… ....
Endo Tools Therapeutics Secures €8 Million ($9.5M) in Series D Funding Led by White Fund Developing innovative, minimally invasive medical devices for gastroenterologists, company plans to seek regulatory clearance in the US and reimbursement in European countries Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices for use by gastroenterologists, today announces the closing of a Series D funding round of €8 million ($9.5M), led by White Fund. The transaction is supported by new private investors and the existing investors (FPIM-SFPI, Epimède, Chagral Invest and private investors). ETT will use the Series D funding to submit a regulatory marketing submission for its medical devices to the Food and Drug Administration (FDA) in the US for soft tissue approximation. ETT also intends to seek further reimbursement within the EU. Lastly, the funding will help to continue R&D efforts into new products and indications, collate evidence on devi ....